Denmark: LEO Pharma turns to a sustainability link to refinance syndicated loan

LEO Pharma, a leader in medical dermatology, has refinanced its syndicated loan facility of Dkr11.2bn (US$1.7bn). The refinancing, facilitated by a consortium of Nordic banks, marks the company’s inaugural sustainability-linked credit facility. The sustainability element of the transaction ties the interest rate paid on the loan to LEO Pharma’s progress on defined sustainability targets. This…

You must be a HMI Subscriber to view this content.

Subscribe Now »